Uteroplacental restriction in the rat impairs fetal growth in association with alterations in placental growth factors including PTHrP.
During pregnancy, parathyroid hormone-related protein (PTHrP) is one of many growth factors that play important roles to promote fetal growth and development, including stimulation of placental calcium transport. Angiotensin II, acting through the AT(1a) receptor, is also known to promote placental growth. We examined the effects of bilateral uterine artery and vein ligation (restriction), which mimics placental insufficiency in humans, on growth, intrauterine PTHrP, placental AT(1a), and pup calcium. Growth restriction was surgically induced on day 18 of pregnancy in Wistar-Kyoto female rats by uterine vessel ligation. Uteroplacental insufficiency reduced fetal body weight by 15% and litter size (P < 0.001) compared with the control rats with no effect on placental weight or amniotic fluid volume. Uteroplacental insufficiency reduced placental PTHrP content by 46%, with increases in PTHrP (by 2.6-fold), parathyroid hormone (PTH)/PTHrP receptor (by 11.6-fold), and AT(1a) (by 1.7-fold) relative mRNA in placenta following restriction compared with results in control (P < 0.05). There were no alterations in uterine PTHrP and PTH/PTHrP receptor mRNA expression. Maternal and fetal plasma PTHrP and calcium concentrations were unchanged. Although fetal total body calcium was not altered, placental restriction altered perinatal calcium homeostasis, as evidenced by lower pup total body calcium after birth (P < 0.05). The increased uterine and amniotic fluid PTHrP (P < 0.05) may be an attempt to compensate for the induced impaired placental function. The present study demonstrates that uteroplacental insufficiency alters intrauterine PTHrP, placental AT(1a) expression, and perinatal calcium in association with a reduction in fetal growth. Uteroplacental insufficiency may provide an important model for exploring the early origins of adult diseases.
Wlodek
Mary E
ME
Department of Physiology, University of Melbourne, Victoria 3010, Australia. m.wlodek@unimelb.edu.au
Westcott
Kerryn T
KT
O'Dowd
Rachael
R
Serruto
Anne
A
Wassef
Lesley
L
Moritz
Karen M
KM
Moseley
Jane M
JM
D000653:Amniotic Fluid / Q000378:metabolism; D000818:Animals; D001835:Body Weight / Q000502:physiology; D002118:Calcium / Q000097:blood / Q000378:metabolism; D015342:DNA Probes; D003851:Deoxyribonucleases / Q000096:biosynthesis; D004195:Disease Models, Animal; D005260:Female; D047109:Fetal Development / Q000502:physiology*; D015870:Gene Expression; D006133:Growth Substances / Q000097:blood / Q000378:metabolism / Q000502:physiology*; D009929:Organ Size / Q000502:physiology; D044162:Parathyroid Hormone-Related Protein / Q000097:blood / Q000378:metabolism* / Q000502:physiology*; D010920:Placenta / Q000502:physiology*; D010927:Placental Insufficiency / Q000503:physiopathology; D011247:Pregnancy; D012313:RNA / Q000096:biosynthesis; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D011921:Rats, Inbred WKY; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014599:Uterus / Q000502:physiology*
D015342:DNA Probes; D006133:Growth Substances; D044162:Parathyroid Hormone-Related Protein; D012333:RNA, Messenger; D012313:RNA; D003851:Deoxyribonucleases; D002118:Calcium